| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Neuroblastoma amplified sequence (NBAS) from ORIGENE TECHNOLOGIES | LY414312 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuroblastoma breakpoint family, member 15 (NBPF15), transcript variant 2 from ORIGENE TECHNOLOGIES | LY406526 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuroblastoma breakpoint family, member 4 (NBPF4) from ORIGENE TECHNOLOGIES | LY428449 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuroblastoma breakpoint family, member 6 (NBPF6), transcript variant 1 from ORIGENE TECHNOLOGIES | LY428447 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuroblastoma RAS viral (v-ras) oncogene homolog (NRAS) from ORIGENE TECHNOLOGIES | LY400901 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuroblastoma, suppression of tumorigenicity 1 (NBL1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY417336 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421783 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425715 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421784 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425716 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 3 from ORIGENE TECHNOLOGIES | LY421785 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 3 from ORIGENE TECHNOLOGIES | LY425717 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 4 from ORIGENE TECHNOLOGIES | LY421786 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 4 from ORIGENE TECHNOLOGIES | LY425718 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 5 from ORIGENE TECHNOLOGIES | LY421787 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 5 from ORIGENE TECHNOLOGIES | LY425719 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 6 from ORIGENE TECHNOLOGIES | LY421788 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 6 from ORIGENE TECHNOLOGIES | LY425720 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 7 from ORIGENE TECHNOLOGIES | LY421789 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 7 from ORIGENE TECHNOLOGIES | LY425721 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 8 from ORIGENE TECHNOLOGIES | LY410350 | 100 ug | ORIGENE TECHNOLOGIES |
| HSBP1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401399 | 1 kit | ORIGENE TECHNOLOGIES |
| HS1BP3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408668 | 1 kit | ORIGENE TECHNOLOGIES |
| Hs1bp3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN507949 | 1 kit | ORIGENE TECHNOLOGIES |
| Hsbp1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN507960 | 1 kit | ORIGENE TECHNOLOGIES |
| HSBP1L1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN427621 | 1 kit | ORIGENE TECHNOLOGIES |
| Hsbp1l1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN507961 | 1 kit | ORIGENE TECHNOLOGIES |
| HS1BP3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH308668 | 10 ug | ORIGENE TECHNOLOGIES |
| HSBP1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301399 | 10 ug | ORIGENE TECHNOLOGIES |
| Neuroepithelial cell transforming 1 (NET1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425812 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuroepithelial cell transforming 1 (NET1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY401777 | 100 ug | ORIGENE TECHNOLOGIES |
| Neuroepithelial cell transforming 1 (NET1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420761 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurofascin (NFASC), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431680 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurofascin (NFASC), transcript variant 5 from ORIGENE TECHNOLOGIES | LY431534 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurofascin (NFASC), transcript variant 6 from ORIGENE TECHNOLOGIES | LY431529 | 100 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 1 (EXOSC1) from ORIGENE TECHNOLOGIES | TP306007 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 2 (EXOSC2) from ORIGENE TECHNOLOGIES | TP300753 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 5 (EXOSC5) from ORIGENE TECHNOLOGIES | TP310665 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 8 (EXOSC8) from ORIGENE TECHNOLOGIES | TP304768 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 3 (EXOSC3), transcript variant 1 from ORIGENE TECHNOLOGIES | TP300035 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 7 (EXOSC7), transcript variant 1 from ORIGENE TECHNOLOGIES | TP301419 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 9 (EXOSC9), transcript variant 1 from ORIGENE TECHNOLOGIES | TP323537 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exosome component 3 (EXOSC3), transcript variant 2 from ORIGENE TECHNOLOGIES | TP318361 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exostoses (multiple)-like 1 (EXTL1) from ORIGENE TECHNOLOGIES | TP309064 | 20 ug | ORIGENE TECHNOLOGIES |
| Human exostoses (multiple)-like 2 (EXTL2), transcript variant 1 from ORIGENE TECHNOLOGIES | TP307406 | 20 ug | ORIGENE TECHNOLOGIES |
| Human prohibitin (PHB) from ORIGENE TECHNOLOGIES | TP301229 | 20 ug | ORIGENE TECHNOLOGIES |
| Human extracellular matrix protein 1 (ECM1), transcript variant 1 from ORIGENE TECHNOLOGIES | TP301118 | 20 ug | ORIGENE TECHNOLOGIES |
| Human Extremities; Histiocytoma, malignant fibrous, metastatic from ORIGENE TECHNOLOGIES | CS607224 | 5x5um | ORIGENE TECHNOLOGIES |
| Shisa homolog 2 (Xenopus laevis) (SHISA2) from ORIGENE TECHNOLOGIES | LY423505 | 100 ug | ORIGENE TECHNOLOGIES |
| Shisa homolog 3 (Xenopus laevis) (SHISA3) from ORIGENE TECHNOLOGIES | LY421060 | 100 ug | ORIGENE TECHNOLOGIES |